GENOMESCORE Trademark

Trademark Overview

On Friday, January 2, 2026, a trademark application was filed for GENOMESCORE with the United States Patent and Trademark Office. The USPTO has given the GENOMESCORE trademark a serial number of 99575973. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, May 8, 2026. This trademark is owned by Seragon Pharmaceuticals Inc.. The GENOMESCORE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Genetic identity tests comprised of reagents for medical purposes; Diagnostic preparations for medical purposes for detecting genetic predispositions; Preparations for detecting genetic predispositions for medical purposes; Reagents for use in medical genetic testing; Diagnostic biomarkers for use in assessment of genomic analysis for medical use; Diagnostic preparations for use in assessment of genomic analysis for medical use

Genetic testing for scientific research purposes; Genetic mapping for scientific purposes; Consulting services in the field of genetic science; Providing medical research information in the field of genetics; Chemical, biochemical, biological and bacteriological research and analysis; Genotyping services for research or analysis purposes; Biological research and analysis; Biochemical research and analysis
genomescore

General Information

Serial Number99575973
Word MarkGENOMESCORE
Filing DateFriday, January 2, 2026
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, May 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkGENOME SCORE
Goods and ServicesGenetic identity tests comprised of reagents for medical purposes; Diagnostic preparations for medical purposes for detecting genetic predispositions; Preparations for detecting genetic predispositions for medical purposes; Reagents for use in medical genetic testing; Diagnostic biomarkers for use in assessment of genomic analysis for medical use; Diagnostic preparations for use in assessment of genomic analysis for medical use
Goods and ServicesGenetic testing for scientific research purposes; Genetic mapping for scientific purposes; Consulting services in the field of genetic science; Providing medical research information in the field of genetics; Chemical, biochemical, biological and bacteriological research and analysis; Genotyping services for research or analysis purposes; Biological research and analysis; Biochemical research and analysis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 2, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 2, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSeragon Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
US

Trademark Events

Event DateEvent Description
Friday, January 2, 2026NEW APPLICATION ENTERED
Friday, January 2, 2026APPLICATION FILING RECEIPT MAILED
Thursday, April 23, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 1, 2026ASSIGNED TO EXAMINER
Friday, May 8, 2026NON-FINAL ACTION WRITTEN
Friday, May 8, 2026NON-FINAL ACTION E-MAILED
Friday, May 8, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

genomescore genetic medical purposes research analysis preparations diagnostic scientific biological reagents